Kanda S - Search Results

1

Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report.

Yazaki T, Kimoto M, Minagawa A, Maruno T, Yamanaka M, Sonehara K, Hama M, Nakamura T, Kanda S, Hanaoka M, Hachiya T. Yazaki T, et al. Among authors: kanda s. Am J Case Rep. 2024 Jun 1;25:e943466. doi: 10.12659/AJCR.943466. Am J Case Rep. 2024. PMID: 38822519 Free PMC article.

2

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease.

Fujimoto K, Kitaguchi Y, Kanda S, Urushihata K, Hanaoka M, Kubo K. Fujimoto K, et al. Among authors: kanda s. Int J Chron Obstruct Pulmon Dis. 2011;6:219-27. doi: 10.2147/COPD.S18461. Epub 2011 Apr 1. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21660299 Free PMC article.

3

Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.

Agatsuma T, Koizumi T, Kanda S, Ito M, Urushihata K, Yamamoto H, Hanaoka M, Kubo K. Agatsuma T, et al. Among authors: kanda s. J Thorac Oncol. 2011 Dec;6(12):2130-4. doi: 10.1097/JTO.0b013e31822e71c0. J Thorac Oncol. 2011. PMID: 21892103 Free article.

4

Prospective study of gefitinib readministration after chemotherapy in patients with advanced non-small-cell lung cancer who previously responded to gefitinib.

Koizumi T, Agatsuma T, Ikegami K, Suzuki T, Kobayashi T, Kanda S, Yoshikawa S, Kubo K, Shiina T, Takasuna K, Matsuo A, Hayasaka M, Morikawa M, Ameshima S. Koizumi T, et al. Among authors: kanda s. Clin Lung Cancer. 2012 Nov;13(6):458-63. doi: 10.1016/j.cllc.2012.01.006. Epub 2012 Mar 7. Clin Lung Cancer. 2012. PMID: 22402083 Clinical Trial.

5

Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy.

Kanda S, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Kubota K, Tamura T, Ohe Y. Kanda S, et al. Lung Cancer. 2015 Sep;89(3):287-93. doi: 10.1016/j.lungcan.2015.06.016. Epub 2015 Jul 2. Lung Cancer. 2015. PMID: 26169499

6

Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.

Seki Y, Fujiwara Y, Kohno T, Takai E, Sunami K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Watanabe S, Ichikawa H, Yamamoto N, Kuwano K, Ohe Y. Seki Y, et al. Among authors: kanda s. Oncologist. 2016 Feb;21(2):156-64. doi: 10.1634/theoncologist.2015-0288. Epub 2016 Jan 14. Oncologist. 2016. PMID: 26768482 Free PMC article.

7

Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer.

Noda S, Kanda S. Noda S, et al. Among authors: kanda s. Expert Rev Respir Med. 2016;10(5):547-56. doi: 10.1586/17476348.2016.1164603. Epub 2016 Mar 28. Expert Rev Respir Med. 2016. PMID: 26959310 Review.

8

Comparative analysis of PET findings and clinical outcome in patients with primary mediastinal seminoma.

Koizumi T, Katou A, Ikegawa K, Kosaka M, Tateishi K, Yokoyama T, Ushiki A, Kanda S, Tsushima K, Yamamoto H, Hanaoka M, Kubo K, Yoshida K, Oguchi K. Koizumi T, et al. Among authors: kanda s. Thorac Cancer. 2013 Aug;4(3):241-248. doi: 10.1111/1759-7714.12002. Thorac Cancer. 2013. PMID: 28920241 Free article.

9

Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.

Sonehara K, Tateishi K, Komatsu M, Yamamoto H, Hanaoka M, Kanda S, Koizumi T. Sonehara K, et al. Among authors: kanda s. Chemotherapy. 2019;64(3):129-137. doi: 10.1159/000502681. Epub 2019 Oct 17. Chemotherapy. 2019. PMID: 31622969

10

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.

Creelan BC, Yeh TC, Kim SW, Nogami N, Kim DW, Chow LQM, Kanda S, Taylor R, Tang W, Tang M, Angell HK, Roudier MP, Marotti M, Gibbons DL. Creelan BC, et al. Among authors: kanda s. Br J Cancer. 2021 Jan;124(2):383-390. doi: 10.1038/s41416-020-01099-7. Epub 2020 Oct 5. Br J Cancer. 2021. PMID: 33012782 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

802 results

Search Page

Filters